838
Panorama Actual del Medicamento
PLANTAS MEDICINALES
ni durante el embarazo y periodo de lactancia. Igual-
mente debe evitarse su administración conjunta con
fármacos sedantes, hipnóticos y anticonvulsivantes.
La raíz de otra especie del mismo género,
Scute-
llaria baicalensis
, conocida como “Chinese skullcap”
originaria de China y Rusia, es utilizada en la medi-
cina tradicional China por sus propiedades analgé-
sicas, antiinflamatorias, antialérgicas, antifúngicas,
antivirales, antioxidantes, antitumorales, etc. Ensayos
en cultivos celulares han demostrado también su ac-
tividad neuroprotectora y asimismo ensayos en ani-
males de experimentación indican para esta planta
propiedades hipoglucemiantes, hipotensoras y ansio-
líticas. De sus raíces se han aislado cuatro flavonas
que han mostrado en un ensayo
in vitro
afinidad,
en mayor o menor grado, por el receptor GABAA en
sinaptosomas de ratón. Estas flavonas se han aislado
también en
S. lateriflora
.
Bibliografía
–
–
Agha-Hosseini M, Kashani L, Aleyaseen A
et al. Crocus sativus
L.
(saffron) in the treatment of premenstrual síndrome: a double-
blind, randomized and placebo-controlled trial.
BJOG
2008,
115(4): 515-9.
–
–
Akhondzadeh S, Fallah-Pour H, Afkham K
et al.
Compari-
son of
Crocus sativus
L. and imipramine in the treatment of
mild to moderate depression: a pilot double-blind randomi-
zed trial [ISRCTN45683816].
BMC Complement Altern Med
2004, 4:12.
–
–
Amsterdam JD, Li Y, Soeller I
et al
.
A randomized, double-blind,
placebo-controlled trial of oral
Matricaria recutita
(Chamomile)
extract of generalized anxiety disorder.
J Clin Psychopharmacol
2009, 29(4): 378-82.
–
–
Amsterdam JD, Shults J, Soeller I
et al
.
Chamomile (
Matricaria
recutita
) may provide antidepressant activity in anxious, depres-
sed humans: an exploratory study.
Altern Ther HealthMed
2012,
18(5): 44-9.
–
–
Avallone R, Zanoli P, Puia G
et al.
Pharmacological profile of api-
genin, a flavonoid isolated from
Matricaria chamomilla.
Biochem
Pharmacol
2000, 59(11): 1387-94.
–
–
Awad R, Arnason JT, Trudeau V
et al.
Phytochemical and biologi-
cal analysis of skullcap (
Scutellaria lateriflora
L.): a medicinal plant
with anxiolytic properties.
Phytomedicine
2003, 10(8): 640-9.
–
–
Basti AA, Moshiri E, Noorbala AA
et al
.
Comparison of petal of
Crocus sativus
L. and fluoxetine in the treatment of depressed
outpatients: a pilot double-blind randomized trial.
Prog Neurops-
ychopharmacol Biol Psychiatry
2007, 31(2): 439-42.
–
–
Can OD, Demir Özkay U, Kiyan HT, Demirci B. Psychopharmaco-
logical profile of Chamomile (
Matricaria recutita
L.) essential oil in
mice.
Phytomedicine
2012, 19(3-4): 306-10.
–
–
Della Loggia R, Traversa U, Scarcia V, Tubaro A. Depressive effects
of
Chamomilla recutita
(L). Rausch, tubular flowers, on central
nervous system in mice.
Pharmacol Res Commun
1982,
14(2):
153-62.
–
–
Georgiadou G, Tarantilis PA, Pitsikas N. Effects of the active
constituents of
Crocus sativus
L., crocins, in an animal model of
obsessive-compulsive disorder.
Neurosci Lett
2012, 528(1): 27-30.
–
–
Geromichalos GD, Lamari FN, Papandreou MA
et al.
Saffron as a
source of novel acetylcholinesterase inhibitors: molecular docking
and
in vitro
enzymatic studies.
J Agric Food Chem
2012, 60(24):
6131-8.
–
–
Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of
Crocus sativus
aqueous extract and its constituents, crocin and
safranal, in mice.
Phytother Res
2009, 23(6): 768-74.
–
–
Hosseinzadeh H, Sadeghnia HR. Protective effect of safranal on
pentylenetetrazol-induced seizures in the rat: involvement of the
GABAergic and opioids systems.
Phytomedicine
2007, 14(4): 256-
62.
–
–
Lechtenberg M, Schepmann D, Niehues M
et al.
Quality and
functionality of saffron: quality control, species assortment and
affinity of extract and isolated saffron compounds to NMDA and
sigma1 (sigma-1) receptors.
Planta Med
2008, 74(7):764-72.
–
–
Masaki M, Aritake K, Tanaka H
et al.
Crocin promotes non-rapid
eye movement sleep in mice.
Mol Nutr Food Res
2012, 55(2):
304-8.
–
–
Moshiri E, Basti AA, Noorbala AA
et al
.
Crocus sativus
L. (petal)
in the treatment of mild-to-moderate depression: a double-blind,
randomized and placebo-controlled trial.
Phytomedicine
2006,
13(9-10): 607-11.
–
–
Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH.
Hydro-alcoholic extract of
Crocus sativus
L.
versus
fluoxetine in
the treatment of mild to moderate depression: a double-blind,
randomized pilot trial.
J Ethnopharmacol
2005, 97(2): 281-4.
–
–
Park HG, Yoon SY, Choi JY
et al
.
Anticonvulsant effect of wogo-
nin isolated from
Scutellaria baicalensis
.
Eur J Pharmacol
2007,
574(2-3): 112-9.
–
–
Pitsikas N, Boultadakis A, Georgiadou G
et al
.
Effects of the active
constituents of
Crocus sativus
L., crocins, in an animal model of
anxiety.
Phytomedicine
2008, 15(12): 1135-9.
–
–
Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: Pharma-
cology and clinical uses.
Wien Med Wochenschr
2007, 157(13-
14): 315-9.
–
–
Srivastava R, Ahmed H, Dixit RK
et al
.
Crocus sativus
L.: A compre-
hensive review.
Pharmacogn Rev
2010, 4(8): 200-8.
–
–
Vanaclocha B, Cañigueral S. Fitoterapia. Vademecumde prescrip-
ción. 4ª edición, Masson, 2003.
–
–
Viola H, Wasowski C, Levi de Stein M
et al
.
Apigenin, a compo-
nent of
Matricaria recutita
flowers, is a central benzodiazepine
receptors-ligand with anxiolytic effects.
Planta Med
1995, 61(3):
213-6.
–
–
Wan Y, Han T, Zhu Y
et al.
Antidepressant properties of bioactive
fractions from the extract of
Crocus sativus
L.
J Nat Med
2010,
64(1): 24-30.
–
–
Wolfson P, Hoffmann DL. An investigation into the efficacy of
Scutellaria lateriflora
in healthy volunteers.
Altern Ther Health
Med
2003, 9(2): 74-8.
–
–
Zhang Z, Lian XY, Li S, Stringer JL. Characterization of chemical
ingredients and anticonvulsant activity of American skullcap (
Scu-
tellaria lateriflora
).
Phytomedicine
2009, 16(5): 485-93.
–
–
Zick SM, Wright BD, Sen A, Arnedt JT. Preliminary examination
of the efficacy and
–
–
safety of a standardized chamomile extract for chronic primary
insomnia: A randomized placebocontrolled pilot study.
BMC
Complement AlternMed
2011, 11:78. doi: 10.1186/1472-6882-
11-78.
